ClearBatch

Most peptide accounts just post before/after pics and hype. Zero mention of testing. Here’s the ugly truth, the majority of “research” peptides on the market fail basic purity tests. Real COA checklist you MUST demand: -HPLC for purity (>98%) -Endotoxin (LAL) test -Heavy metals - Sterility We run ClearBatch exactly because we got tired of seeing guys ruin their health with dirty batches. If it doesn't provide at least 2-3 of these tests move on If you’re serious about peptides, lookmaxing, or biohacking without gambling your health follow @clearbatchnet

Creatine is not some spooky “fake chemical.” It’s a naturally occurring compound found in your body and in foods like red meat and fish. Supplementing it is basically just a more efficient way to get a useful dose without needing to eat steak and sardines like it’s a full-time job. Eat whole foods, sure. But “made in a lab” is not an argument.

stop taking creatine and eat steak & sardines instead creatine is fake chemical powder made in a lab

@muscleforlife Easier said than done. That's why magic meds/pills are so popular.

Ironic: Research shows average calorie deficit in GLP1 users is 300-700 kcal/day. So skipping dessert.

@BioLongevityUSA If you're going to stack peptides you better know what you're putting in your body. Verifiable COAs with trading for purity, endotoxins, metals are a must.

$50 Billion Market. No Standard for Proof. Over 110 peptides are approved globally. Hundreds of suppliers. Most can't verify what's in the vial. The peptide therapeutics market is valued at $49.68 billion in 2026 - projected to reach $70.2 billion by 2031. In the United States alone, the number is $65.1 billion, on pace for $160.3 billion by 2030. That's a 14.7% CAGR. Over 110 peptides have been approved globally. Four new FDA approvals came in 2024 alone. North America holds roughly 40% of worldwide revenue. The growth story is real. What's not being examined is the supply chain underneath it. ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ The Supply Chain Problem Everyone talks about which peptide to buy. Nobody talks about what's in the vial. The peptide synthesis market - the companies actually manufacturing these compounds - sits at $1.9 billion and is projected to reach $2.59 billion by 2031. The growing number of suppliers entering the market has expanded options significantly. Some are serious. Many are not. And the gap between research-grade and "we printed a label" is enormous - but invisible to anyone who doesn't know what to look for. The technology has advanced. Microwave-assisted solid-phase synthesis now pushes crude purity above 90% while cutting production time from hours to minutes. CPC Scientific is opening a new U.S. facility in 2026 to meet domestic API demand. But more suppliers hasn't meant better quality. It's meant more noise. The ones cutting corners look identical on the surface to the ones doing the work. ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ What Quality Actually Means Two analytical methods form the backbone of peptide verification. HPLC separates a peptide from impurities and reports purity as a percentage. Above 99% is the research standard. Mass spectrometry confirms molecular identity by matching observed weight to the intended sequence. The critical point most buyers miss: HPLC alone cannot confirm you have the right compound. It tells you how pure something is. Mass spectrometry tells you what it is. Both must appear on every COA. A purity percentage without a chromatogram is not documentation - it's a marketing claim. ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ The Conflict of Interest When a supplier tests their own product, they're grading their own homework. In-house testing creates structural bias. Third-party labs eliminate that bias. When multiple independent labs verify the same batch and agree, the confidence level is fundamentally different. Triple third-party testing - three independent certified labs per batch - is the highest available standard. ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ Red Flags That Should End the Conversation COAs without batch numbers - generic or copied documents. Purity percentage with no chromatogram - unverified claim. No mass spectrometry data - molecular identity not confirmed. Reused COAs across products - mislabeling risk. Analytical data only after purchase - non-transparent sourcing. Inconsistent COA formatting - unstable documentation processes. Any of these introduces uncertainty into compound identity and purity - uncertainty that directly undermines research reproducibility. ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ Who Meets the Standard At the enterprise level, Bachem (50+ years, Switzerland) represents the documentation ceiling. GenScript handles complex custom synthesis. CPC Scientific, Thermo Fisher, and Phoenix Pharmaceuticals serve institutional procurement. For the broader research market: BioLongevity Labs - USA GMP-certified, 150+ compounds, triple third-party tested (three independent labs per batch). Full analytical dossier ships with every order: COAs from all three labs, HPLC chromatograms, LC-MS confirmation, sterility testing, MSDS. All documentation accessible pre-purchase. ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ Where Research Is Concentrated in 2026 BPC-157 - tissue repair, angiogenesis models. TB-500 - actin polymerization, cell motility. GHK-Cu - collagen synthesis, fibroblast culture (research since the 1970s). Semax - neuroprotection, BDNF expression. Thymulin - immune cell regulation. Bioregulators (Cardiogen, Pinealon) - organ-specific gene expression models. All applications are strictly in vitro, and for research use only. ⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ The Bottom Line The market is $50 billion and accelerating. The supplier base is expanding. The documentation gap between serious vendors and everyone else is widening. The minimum standard: batch-specific COAs with HPLC chromatograms and MS confirmation from a named third-party lab. The gold standard: triple third-party verification, full analytical dossier, pre-purchase access. What's in the vial matters more than what's on the label. What's on the COA matters more than what's on the website. All compounds referenced are for research use only. Sources: Mordor Intelligence, Grand View Research. Comment “RESEARCH” and I’ll send you a link to the full research breakdown article.

@rachaelbereba Lookmaxing

Why do Gym bros take peptides and/or TRT?

@JackedBasedMgr Compound count is low. Intensity is not. Also MK-677 is not a peptide, which makes “zero peptides other than that” even better. A short stack can still be a very serious stack.

My stack when this pic was taken 40mg anavar 400mg test 80mg tren On days I had no appetite I supplemented with 10mg mk677 Zero peptides other than that Some of yall take way too much stuff But I’m over here showing 80mg of tren so wtf can I say

@JuliusYRitter What do erections have to do with peptides protocol? Genuinely curious.

Peptides are here to stay & The California Peptide Club will be their nexus in SF. Recap from the club launch: > Injection tutorial on stage > “Who here is on peptides?” Almost all the hands go up. “And who here is on Research-Use Only?” All the hands stay up. Crazy. > 3x oversubbed; people sneaking in through fire exit > Four panels with doctors & experts with 100+ years of cumulative peptide experience > Masterclass on building in consumer health & peptide space w @maxmarchione > Mannequins w @AlmostZara > Peptide fridge & starter kit giveaway for quiz winner > Erections are now commonly used to measure peptide protocol effectiveness > Neuropeptides are the future of cognitive enhancement (Selank > Semax; Dihexa, Noopept) Thanks to the team & @rhobusiness! X @AGIHouseSF On May 16th: injections, pop-up pharmacy, IV drips, peptide protocols. 💉

@shredwithQpid Loyalty

Why is belly fat always the last to leave?

@CoachDanGo "I wanna get in shape but I'm not willing to move or do anything physical." Ok...

I recently talked to someone who wanted to get in shape. He hated the gym, so I told him to walk. He said that was boring, so I told him to play a sport. He said he couldn't find one he liked, so I told him to forget it. If you keep making excuses, nothing can help you.

@ironnfox Just curious. Did you make sure the peptide batch you were using was tested for purity, endotoxins and metals by verifiable COAs ?

I hardly use peptides anymore because bpc and tb give me anaphylaxis. I can use Ghk, but it’s too expensive to experiment with new stuff only to end up swollen, itchy and throwing away $50. I drove myself to the ER parking lot last time it happened. Always have an antihistamine on hand.

@DrCamRx 💯 you need to know what you're using otherwise you're playing Russian roulette with your health. COA testing that includes ✓ HPLC ✓ Mass Spec ✓ Endotoxin ✓ Sterility and Heavy Metals is really important.

Peptide Bros: “This peptide gives you the benefits of exercise without having to exercise!” Me: Yeah, you’ll run right to the ER when you inject yourself with contaminants, which trigger an allergic reaction that shuts your airway down and you can’t breathe.

@thegarybrecka Not eat bad good by a long shot.

Is it harder to make yourself go to the gym or to not eat bad food?

@AbudBakri The real answer is much less exciting: we do not have enough human data to be this certain either way. That should make serious people more cautious

People saying BPC-157 is 100% safe and no further data needed don’t know what they are talking about People saying BPC-157 causes cancer don’t know what they are talking about

@paulkhls Designing a novel OX2R peptide agonist in 24 hours is a legit AI discovery flex.

🧵 Over 24 hours, our scientific team and AI scientist infrastructure developed a novel peptide agonist to potentially treat ADHD. Below is our paper for a pre-IND computational feasibility assessment for OX2R-004: an 18-residue peptide agonist designed as a selective OX2R agonist for ADHD. Why this matters? No approved orexin agonists exist anywhere. All marketed orexin drugs are dual OX1R/OX2R antagonists for insomnia. Clinical-stage ones are small molecules for narcolepsy only. We did this with @peptai_ a novel full 8-gate computational pipeline in one shot developed by @BioProtocol community 👇

Yes absolutely. Pinealon and epitalon will break out, and it won’t be because they became mainstream overnight. It’ll be because they sit right at the intersection of 3 huge markets: •longevity •cognition / performance •low-friction peptide use That is a massive commercial setup.

pinealon and epitalon will both do billions in sales individually before 2030

@LeddyLLC I'll never understand why most ppl that care about their health don't run a full blood test panel every 6 months to keep an eye on their vitamin levels.

Three deficiencies that quietly destroy your hormones: 1. Magnesium - cortisol stays elevated, sleep stays shallow 2. Zinc - testosterone production slows, immunity weakens 3. Vitamin D - insulin sensitivity drops, mood regulation suffers Most people are low in all three. Most doctors never test for any of them.

@AntiDoc Creatine compared to peptides has been tried and tested over decades already. No-brainer.

I don’t care what any of you say. Creatine is ridiculously cognitively impactful. The pumps and fullness are even more pronounced. Given the evidence, anecdotes, and price, it’s braindead to save your 13 cents per day because you “don’t feel it.” Objectively ridiculous hill to die on.

We've put a lot of work into this to improve peptides sourcing safety and testing for all of you. A whiter shade of grey for the market. ClearBatch.net

@MichaelAlbertMD BPC-157 has pro-angiogenic preclinical data, which means a cancer-risk concern is not crazy or conspiratorial. But people should be precise: plausible risk is not the same thing as proven human carcinogenicity.

It's biologically plausible that BPC-157 promotes cancer via its angiogenic properties. Right now, the only way we'll know is after people develop cancer through recreational, gray market use. If you don't recognize how problematic that is, I don't know what to tell you.

This is probably where the market is headed. Use injections for the big weight-loss phase. Use an oral for maintenance once most of the work is done. That solves a lot: - less injection fatigue - fewer storage/travel issues - lower psychological friction - easier long-term adherence The whole game is whether the pill can actually preserve enough of the benefit after transition.

This is actually great news for anyone on GLP-1 injections. The path forward is getting simpler: lose weight on shots, maintain on a daily pill. No more weekly injections, no more refrigeration, no more hiding your pen at family dinners. Progress.